Sustainability governance

Robust governance is crucial to ensuring that we can deliver on our sustainability priorities, create long-term value for stakeholders and operate responsibly and ethically. 

Identifying our material sustainability topics

In 2024, we conducted a double materiality assessment to identify material sustainability-related risks and opportunities for AstraZeneca. This is outlined in our Annual Report.

Sustainability governance

Our sustainability strategy, developed by the Senior Executive Team (SET), is executed under the oversight of the Board Sustainability Committee. The Board Audit Committee ensures the integrity of sustainability reporting and assurance.

The Sustainability Strategy Steering Committee, led by the VP of Global Sustainability and SHE, drives strategic advancements, while the Sustainability Reporting Steering Committee, chaired by the SVP Finance, Group Controller, and Head of Global Finance, ensures alignment with reporting regulations and internal standards. Both committees regularly report progress to the Board’s Audit and Sustainability Committees and update the SET on developments.

Benchmarking and assurance

We contribute to key global environmental, social and governance (ESG) performance evaluations, recognising the value of independent third-party assessment and insights. Our performance is also assessed independently based on the information and data we make publicly available.